Document/ExhibitDescriptionPagesSize 1: 8-K Current Report HTML 24K
5: R1 Cover Page HTML 46K
7: XML IDEA XML File -- Filing Summary XML 11K
10: XML XBRL Instance -- hqy-20240411_htm XML 14K
6: EXCEL IDEA Workbook of Financial Report Info XLSX 8K
3: EX-101.LAB XBRL Labels -- hqy-20240411_lab XML 64K
4: EX-101.PRE XBRL Presentations -- hqy-20240411_pre XML 34K
2: EX-101.SCH XBRL Schema -- hqy-20240411 XSD 10K
8: JSON XBRL Instance as JSON Data -- MetaLinks 12± 17K
9: ZIP XBRL Zipped Folder -- 0001428336-24-000018-xbrl Zip 13K
(Address, including Zip Code, and Telephone Number, including Area Code, of Registrant’s Principal Executive Offices)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2):
i☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
i☐Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
i☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
i☐Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
iCommon stock, par value $0.0001 per share
iHQY
iThe
NASDAQ Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company i☐
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 7.01 Regulation FD Disclosure
As disclosed previously, on September 18, 2023, HealthEquity entered into a Custodial Transfer and Asset Purchase Agreement with Conduent Business Services, LLC, related to the transfer to HealthEquity of Conduent’s health savings account ("HSA") portfolio in a series of three tranches. On April 11, 2024, the second of the three HSA asset transfers occurred, with approximately
134,000 HSAs and $555 million of HSA assets transferring to HealthEquity’s custody. In connection with this transfer, HealthEquity paid the applicable purchase price of $84.9 million using $50.0 million of borrowings under its revolving credit facility, with the remainder paid using cash on hand.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
Exhibit No.
Description
104
Cover Page Interactive Data File (formatted in Inline XBRL)
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
